Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HENRY RODRIGUEZ

Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology

NPI
1962434662
CMS profile
179371
Location
TAMPA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$81,147.34

58 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
SANOFI-AVENTIS U.S. LLC $77,874.44 51
Merck Sharp & Dohme LLC $1,395.00 1
Mannkind Corporation $1,317.50 2
Sequel Med Tech, LLC $155.96 1
BETA BIONICS, INC. $144.72 1
Neurocrine BioSciences, Inc. $133.88 1
Tandem Diabetes Care, Inc. $125.84 1

Page 1 of 2; records 1–50 of 58 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HENRY RODRIGUEZ

NPI 1962434662 · CMS profile ID 179371

Allopathic & Osteopathic Physicians / Pediatrics / Pediatric Endocrinology

TAMPA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 58 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1962434662?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HENRY RODRIGUEZ, NPI 1962434662, CMS profile ID 179371. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 58 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1962434662?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). HENRY RODRIGUEZ, NPI 1962434662, CMS profile ID 179371. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 58 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1962434662?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
HENRY RODRIGUEZ, NPI 1962434662, CMS profile ID 179371, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 58 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1962434662?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

58 matching records · $81,147.34 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 58 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 58.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Sequel Med Tech, LLC $155.9611/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243750180 CMS
Mannkind Corporation $42.5010/09/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1250882274 CMS
SANOFI-AVENTIS U.S. LLC $142.0009/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698735 CMS
SANOFI-AVENTIS U.S. LLC $5,152.5009/30/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1233698737 CMS
SANOFI-AVENTIS U.S. LLC $128.6609/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698739 CMS
Neurocrine BioSciences, Inc. $133.8809/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1242963817 CMS
SANOFI-AVENTIS U.S. LLC $3,870.0009/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698723 CMS
SANOFI-AVENTIS U.S. LLC $52.9209/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698725 CMS
SANOFI-AVENTIS U.S. LLC $118.3008/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698705 CMS
SANOFI-AVENTIS U.S. LLC $3,225.0008/27/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698707 CMS
SANOFI-AVENTIS U.S. LLC $25.2008/27/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698709 CMS
SANOFI-AVENTIS U.S. LLC $7,740.0007/29/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698697 CMS
SANOFI-AVENTIS U.S. LLC $476.3707/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698699 CMS
SANOFI-AVENTIS U.S. LLC $2,902.5007/29/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698713 CMS
SANOFI-AVENTIS U.S. LLC $328.8307/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698715 CMS
SANOFI-AVENTIS U.S. LLC $30.6507/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698717 CMS
SANOFI-AVENTIS U.S. LLC $44.0007/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698719 CMS
SANOFI-AVENTIS U.S. LLC $123.1107/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698721 CMS
SANOFI-AVENTIS U.S. LLC $1,935.0007/22/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698691 CMS
Mannkind Corporation $1,275.0007/01/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1250882272 CMS
Tandem Diabetes Care, Inc. $125.8405/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241281271 CMS
SANOFI-AVENTIS U.S. LLC $121.8304/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698675 CMS
SANOFI-AVENTIS U.S. LLC $7,740.0004/30/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698677 CMS
SANOFI-AVENTIS U.S. LLC $170.0904/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698679 CMS
SANOFI-AVENTIS U.S. LLC $352.1804/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698681 CMS
SANOFI-AVENTIS U.S. LLC $188.4004/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698683 CMS
SANOFI-AVENTIS U.S. LLC $71.8104/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698685 CMS
SANOFI-AVENTIS U.S. LLC $655.6104/30/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698687 CMS
SANOFI-AVENTIS U.S. LLC $149.9804/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698663 CMS
SANOFI-AVENTIS U.S. LLC $3,708.0004/17/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698695 CMS
SANOFI-AVENTIS U.S. LLC $116.9803/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698655 CMS
SANOFI-AVENTIS U.S. LLC $3,547.5003/13/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698657 CMS
SANOFI-AVENTIS U.S. LLC $25.2003/13/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698659 CMS
SANOFI-AVENTIS U.S. LLC $2,257.5003/11/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698661 CMS
SANOFI-AVENTIS U.S. LLC $120.1803/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698665 CMS
SANOFI-AVENTIS U.S. LLC $3,547.5003/10/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698667 CMS
SANOFI-AVENTIS U.S. LLC $25.2003/10/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698669 CMS
SANOFI-AVENTIS U.S. LLC $7,740.0003/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698731 CMS
SANOFI-AVENTIS U.S. LLC $63.5703/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698741 CMS
SANOFI-AVENTIS U.S. LLC $70.4803/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698743 CMS
SANOFI-AVENTIS U.S. LLC $362.5603/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698745 CMS
SANOFI-AVENTIS U.S. LLC $586.7203/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698747 CMS
SANOFI-AVENTIS U.S. LLC $426.3603/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698749 CMS
SANOFI-AVENTIS U.S. LLC $8,062.5002/14/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233698641 CMS
SANOFI-AVENTIS U.S. LLC $445.3502/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698643 CMS
SANOFI-AVENTIS U.S. LLC $770.3402/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698645 CMS
SANOFI-AVENTIS U.S. LLC $123.4802/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233698647 CMS
SANOFI-AVENTIS U.S. LLC $22.0002/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698649 CMS
SANOFI-AVENTIS U.S. LLC $57.9002/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1233698651 CMS
BETA BIONICS, INC. $144.7202/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246807341 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,245.98 23
PY2020 $4,037.50 3
PY2021 $10,500.00 5
PY2022 $2,550.00 2
PY2023 $28,773.62 31
PY2024 $78,819.50 50
PY2025 $81,147.34 58

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,132.10 8
PY2025 Principal investigator $23,837.57 17
PY2024 Principal investigator $38,121.96 130
PY2023 Recipient $31,152.69 10
PY2023 Principal investigator $334,432.51 152
PY2022 Principal investigator $280,252.64 210
PY2021 Recipient $106.13 2
PY2021 Principal investigator $321,118.06 433
PY2020 Recipient $2,040.00 1
PY2020 Principal investigator $354,412.20 52
PY2019 Principal investigator $133,599.16 29

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

210 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $9,627.75 12/27/2022 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937181199
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $6,825.00 12/09/2022 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937179509
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $44,222.11 12/09/2022 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937179511
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $3,690.00 11/25/2022 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937178897
Principal investigator 1 Novo Nordisk AS $669.99 11/23/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896953703
Principal investigator 1 Novo Nordisk AS $1,260.54 11/23/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897214807
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $2,646.00 11/15/2022 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937178165
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $2,646.00 11/15/2022 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937178167
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $2,750.00 10/11/2022 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937175581
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $3,718.00 10/11/2022 Non-covered Recipient Entity
THE EMMES COMPANY LLC
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937175583
Principal investigator 1 Novo Nordisk AS $3,251.97 09/30/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896953699
Principal investigator 1 Novo Nordisk AS $703.60 08/22/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897131763
Principal investigator 1 Novo Nordisk AS $399.99 07/27/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896896291
Principal investigator 1 Novo Nordisk AS $2,322.76 07/27/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897027535
Principal investigator 1 Novo Nordisk AS $135.00 07/27/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170909
Principal investigator 1 Novo Nordisk AS $135.00 06/29/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896955359
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896887489
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896887493
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896957535
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896957539
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896957543
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896957547
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896957551
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896957627
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896957631
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896959309
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896959313
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897027527
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897028175
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897028183
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897047490
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897047767
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897048362
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897048373
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897053561
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897053564
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897065969
Principal investigator 1 Novo Nordisk AS $30.00 06/16/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897065973
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,586.00 06/14/2022 Non-covered Recipient Entity
THE EMMES CORPORATION
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937170115
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $2,671.50 06/14/2022 Non-covered Recipient Entity
THE EMMES CORPORATION
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937170117
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896880439
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896887417
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896887457
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896887461
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896887465
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896887473
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896887481
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896887485
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896957297
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896957301
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896957531
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896958603
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896958661
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896958667
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896958669
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896958673
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896959305
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896999717
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897021441
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897021445
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897021449
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897027511
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897027515
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897027519
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897027523
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897027539
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897027999
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897028105
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897028159
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897028163
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897028179
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897028187
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897047403
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897047441
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897047447
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897047450
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897047453
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897047459
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897047493
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897047498
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897048357
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897053568
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897053573
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897060673
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897060677
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897060681
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897065966
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897065977
Principal investigator 1 Novo Nordisk AS $36.00 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897065981
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897072690
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897074041
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897074047
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897095385
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897095409
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897095413
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897095417
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897095419
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897120101
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897120356
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897120361
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897131623
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897131747
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897131755
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897131759
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897131767
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897131771
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897169681
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170153
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170159
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170163
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170166
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170249
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170305
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170679
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170901
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170905
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170913
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170917
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170921
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897208845
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897208849
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897208855
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897208859
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897208862
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897208866
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897209027
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897215957
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897217041
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897217089
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897217999
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897224301
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897224305
Principal investigator 1 Novo Nordisk AS $4.50 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897224383
Principal investigator 1 Novo Nordisk AS $5.70 06/02/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897224387
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $36,038.02 05/31/2022 Non-covered Recipient Entity
THE EMMES CORPORATION
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937169063
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $845.00 05/31/2022 Non-covered Recipient Entity
THE EMMES CORPORATION
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937169065
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $37,066.75 05/31/2022 Non-covered Recipient Entity
THE EMMES CORPORATION
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937169071
Principal investigator 1 Novo Nordisk AS $1,559.79 05/25/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896933991
Principal investigator 1 Novo Nordisk AS $1,466.63 05/25/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896962543
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $18,701.13 05/24/2022 Non-covered Recipient Entity
THE EMMES CORPORATION
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937168777
Principal investigator 1 Novo Nordisk AS $135.00 04/29/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896896295
Principal investigator 1 Novo Nordisk AS $703.60 04/29/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896897171
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $4,399.24 03/31/2022 Non-covered Recipient Entity
University Of South Florida
52 wks Eff. & Saf. Ph III in Paediatrics No dispute reported 06/30/2026 965111815
Principal investigator 1 Novo Nordisk AS $135.00 03/25/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896887498
Principal investigator 1 Novo Nordisk AS $135.00 03/25/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896959317
Principal investigator 1 Novo Nordisk AS $4,826.61 03/25/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897027531
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896887503
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896957293
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896959321
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897021433
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897053575
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897060665
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897060669
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897060737
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897065985
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897072686
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897074029
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897074035
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897095389
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897095393
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897095397
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897095401
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897095405
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897120345
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897120349
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897120351
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897126217
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897126221
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897131663
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897131667
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897131675
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897131775
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897131793
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170150
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170253
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170635
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170683
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170691
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897170949
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897208757
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897208763
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897208767
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897217093
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897224025
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897224275
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897224283
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897224287
Principal investigator 1 Novo Nordisk AS $4.50 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897224291
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897224295
Principal investigator 1 Novo Nordisk AS $36.00 03/21/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897224298
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $824.85 03/08/2022 Non-covered Recipient Entity
THE EMMES CORPORATION
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937164491
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $9,074.00 03/07/2022 Non-covered Recipient Entity
University Of South Florida
52 wks Eff. & Saf. Ph III in Paediatrics No dispute reported 06/30/2026 949197241
Principal investigator 1 Novo Nordisk AS $1,000.00 02/25/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897048366
Principal investigator 1 Novo Nordisk AS $135.00 02/25/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897048371
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $4,878.90 02/23/2022 Non-covered Recipient Entity
THE EMMES CORPORATION
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937163991
Principal investigator 1 Eli Lilly and Company $2,940.00 02/08/2022 Non-covered Recipient Entity
UNIV OF SOUTH FLORIDA RSRCH FOUNDATION
A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND COMPARISON OF LY900014 TO HUMALOG WITH AN OPEN-LABEL POSTPRANDIAL LY900014 TREATMENT GROUP IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES No dispute reported 06/30/2026 917836935
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $17,523.94 02/08/2022 Non-covered Recipient Entity
THE EMMES CORPORATION
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937163003
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $20,652.16 02/08/2022 Non-covered Recipient Entity
THE EMMES CORPORATION
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937163005
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $22,560.00 02/08/2022 Non-covered Recipient Entity
THE EMMES CORPORATION
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALOGLIPTIN COMPARED WITH PLACEBO IN PEDIATRIC SUBJECTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 937163007
Principal investigator 1 Novo Nordisk AS $364.00 02/07/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897021309
Principal investigator 1 Novo Nordisk AS $703.60 02/07/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897074037
Principal investigator 1 Novo Nordisk AS $270.00 02/07/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897120097
Principal investigator 1 Novo Nordisk AS $728.00 02/07/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 897126225
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $544.09 01/26/2022 Non-covered Recipient Entity
University Of South Florida
52 wks Eff. & Saf. Ph III in Paediatrics No dispute reported 06/30/2026 949197247
Principal investigator 1 Novo Nordisk AS $6.23 01/25/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896897169
Principal investigator 1 Novo Nordisk AS $6.23 01/25/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896933995
Principal investigator 1 Novo Nordisk AS $6.23 01/25/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896953707
Principal investigator 1 Novo Nordisk AS $27.77 01/25/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896962547
Principal investigator 1 Novo Nordisk AS $6.23 01/25/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896964615
Principal investigator 1 Novo Nordisk AS $6.23 01/25/2022 Non-covered Recipient Entity
UNIVERSITY OF SOUTH FLORIDA BOARD OF TRUSTEES
NN9924-4437 No dispute reported 06/30/2026 896964677